Reuter U, et al. Long-term efficacy and safety of erenumab: Results from 64 weeks of the LIBERTY study. IHC-OR-006. IHC 2019 5-8 sept. Dublin, Ierland.
ECTRIMS 2015 video update Bouma: Parallel Session 2 New challenges in clinical trial design
jun 2017